ECOG (EASTERN COOPERATIVE ONCOLOGY GROUP) PERFORMANCE STATUS SCALE
OBJETIVO
ENLACE DEL INSTRUMENTO
TIPO DE EVALUACIÓN
MODO DE ADMINISTRACIÓN
Es medir la calidad de vida de un paciente exclusivamente con cáncer u oncológico, cuyas expectativas de vida cambian en el transcurso de meses, semanas e incluso días.
Papel y lapiz
Entrevista
COSTO
LIMITACIONES
TIEMPO
-
Dejan de lado aspectos trascendentales como son la realización de actividades básicas e instrumentales de la vida diaria en forma independiente
3-4 minutos
Libre
NÚMERO DE CRITERIOS
CALIFICACIÓN
6 Criterios
(ECOG=0) normal hasta
(ECOG=5) la muerte.
ARTÍCULOS DE REVISIÓN
Young J, Badgery-Parker T, Dobbins T, Jorgensen M, Gibbs P, Faragher I, Jones I, Currow D. Comparison of ECOG/WHO performance status and ASA score as a measure of functional status. J Pain Symptom Manage. 2015 Feb;49(2):258-64. doi: 10.1016/j.jpainsymman.2014.06.006. Epub 2014 Jul 1. PMID: 24996034.
Neeman E, Gresham G, Ovasapians N, Hendifar A, Tuli R, Figlin R, Shinde A. Comparing Physician and Nurse Eastern Cooperative Oncology Group Performance Status (ECOG-PS) Ratings as Predictors of Clinical Outcomes in Patients with Cancer. Oncologist. 2019 Dec;24(12):e1460-e1466. doi: 10.1634/theoncologist.2018-0882. Epub 2019 Jun 21. PMID: 31227648; PMCID: PMC6975959.
Hess LM, Smith D, Cui ZL, Montejano L, Liepa AM, Schelman W, Bowman L. The relationship between Eastern Cooperative Oncology Group performance status and healthcare resource utilization among patients with advanced or metastatic colorectal, lung or gastric cancer. J Drug Assess. 2020 Dec 16;10(1):10-17. doi: 10.1080/21556660.2020.1851504. PMID: 33403155; PMCID: PMC7744150.
Dueck AC, Mendoza TR, Mitchell SA, Reeve BB, Castro KM, Rogak LJ, Atkinson TM, Bennett AV, Denicoff AM, O'Mara AM, Li Y, Clauser SB, Bryant DM, Bearden JD 3rd, Gillis TA, Harness JK, Siegel RD, Paul DB, Cleeland CS, Schrag D, Sloan JA, Abernethy AP, Bruner DW, Minasian LM, Basch E; National Cancer Institute PRO-CTCAE Study Group. Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncol. 2015 Nov;1(8):1051-9. doi: 10.1001/jamaoncol.2015.2639. Erratum in: JAMA Oncol. 2016 Jan;2(1):146. PMID: 26270597; PMCID: PMC4857599.
de Kock I, Mirhosseini M, Lau F, Thai V, Downing M, Quan H, Lesperance M, Yang J. Conversion of Karnofsky Performance Status (KPS) and Eastern Cooperative Oncology Group Performance Status (ECOG) to Palliative Performance Scale (PPS), and the interchangeability of PPS and KPS in prognostic tools. J Palliat Care. 2013 Autumn;29(3):163-9. PMID: 24380215.
Hernández-Quiles C, Bernabeu-Wittel M, Pérez-Belmonte LM, Macías-Mir P, Camacho-González D, Massa B, Maiz-Jiménez M, Ollero-Baturone M; PALIAR investigators. Concordance of Barthel Index, ECOG-PS, and Palliative Performance Scale in the assessment of functional status in patients with advanced medical diseases. BMJ Support Palliat Care. 2017 Sep;7(3):300-307. doi: 10.1136/bmjspcare-2015-001073. Epub 2017 Jan 27. PMID: 28130325.